Benitec Biopharma Inc.
US ˙ NasdaqCM ˙ US08205P2092

SecurityBNTC / Benitec Biopharma Inc.
InstitutionSimplify Asset Management Inc.
Latest Disclosed Ownership562,242 shares
Latest Disclosed Value $ 5,987,877
Simplify Asset Management Inc. reports 271.94% increase in ownership of BNTC / Benitec Biopharma Inc.

On April 27, 2026 - Simplify Asset Management Inc. filed a 13F-HR form disclosing ownership of 562,242 shares of Benitec Biopharma Inc. (US:BNTC) valued at $5,987,877 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 151,163 shares of Benitec Biopharma Inc.. This represents a change in shares of 271.94% during the quarter. The current value of the position is $5,931,653 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BENITEC BIOPHARMA COM NEW 08205P209 562,242 411,079 271.94 5,988 194.06 0.0919
2026-02-09 2025-12-31 13F BENITEC BIOPHARMA COM NEW 08205P209 151,163 72,438 92.01 2,036 84.42 0.0332
2025-10-20 2025-09-30 13F BENITEC BIOPHARMA COM NEW 08205P209 78,725 9,552 13.81 1,105 36.46 0.0203
2025-08-07 2025-06-30 13F BENITEC BIOPHARMA COM NEW 08205P209 69,173 -7,562 -9.85 809 -18.94 0.0407
2025-05-13 2025-03-31 13F BENITEC BIOPHARMA COM NEW 08205P209 76,735 398 0.52 998 3.53 0.0374
2025-02-11 2024-12-31 13F BENITEC BIOPHARMA COM NEW 08205P209 76,337 -40,198 -34.49 964 -9.91 0.0476
2024-11-12 2024-09-30 13F/A-1 BENITEC BIOPHARMA COM NEW 08205P209 116,535 65,319 127.54 1,071 198.88 0.0499
2024-11-06 2024-09-30 13F BENITEC BIOPHARMA COM NEW 08205P209 116,535 65,319 1,071 0.0498
2024-08-12 2024-06-30 13F BENITEC BIOPHARMA COM NEW 08205P209 51,216 51,216 358 0.0240
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.